Provectus Biopharmaceuticals, Inc.
Pharmaceutical company · Knoxville, Tennessee, United States · OTC: PVCT
Provectus Biopharmaceuticals, Inc. is a pharmaceutical company headquartered in Knoxville, Tennessee, United States. Its shares trade on OTC under the ticker PVCT. It has reported private securities offerings to the US SEC, most recently $317,500 sold in a notice filed in 2022.
Provectus Biopharmaceuticals at a glance
What does Provectus Biopharmaceuticals do?
Private fundraising reported to the SEC
17 Form D notices; the most recent reported $317,500 sold (2022).
Frequently asked questions about Provectus Biopharmaceuticals
Where is Provectus Biopharmaceuticals headquartered?
Provectus Biopharmaceuticals, Inc. is headquartered in Knoxville, Tennessee, United States.
What does Provectus Biopharmaceuticals do?
Provectus Biopharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Provectus Biopharmaceuticals a public company?
Yes. Provectus Biopharmaceuticals, Inc. trades on OTC under the ticker PVCT.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences